COSMOS Pharmaceutical Corporation(3349) News

Consolidated Financial Results for the Nine Months Ended February 28, 2026[Japanese GAAP]

COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 0.3％

Market Outlook: Signs of an AI and Chip-Led Rally as Focus Shifts Away from the Middle East

Notice Concerning Organizational and Personnel Changes

Consolidated Financial Results for the Six Months Ended November 30, 2025[Japanese GAAP]

COSMOS Pharma, First Half Ordinary Profit Increases by 1%, Sep-Nov Ordinary Profit Increases by 3%

Consolidated Financial Results for the Three Months Ended August 31, 2025[Japanese GAAP]

COSMOS Pharma, Jun-Aug (1Q) Ordinary Profit Decreases by 1%

View and Policy on Reduction of Investment Unit

Notice Concerning Changes in Directors

Consolidated Financial Results for the Fiscal Year Ended May 31, 2025[Japanese GAAP]

Notice Concerning Distribution of Dividends of Surplus

COSMOS Pharma, 0.1％ Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 5 Yen, This Fiscal Year to Increase Dividend by 5 Yen

[Summary]Consolidated Financial Results for the Nine Months Ended February 28, 2025[Japanese GAAP]

COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%

（Correction）Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]

Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]

COSMOS Pharma, First Half Ordinary Profit Increases by 26%

COSMOS Pharmaceutical Corporation, June-August (1Q) Ordinary Profit Increases by 27%

Consolidated Financial Results for the Three Months Ended August 31, 2024[Japanese GAAP]